Maternal hemoglobin and iron status in early pregnancy and childhood cardiac outcomes

Hugo G Quezada-Pinedo1, Vincent Jaddoe2, Romy Gaillard2

  • 1The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Pediatrics, Division of Neonatology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Insights

Maternal iron status in early pregnancy impacts boys' heart function long-term. Anemia was linked to larger heart volumes in boys, suggesting a sex-specific effect on cardiovascular development.

Area of Science:

  • Cardiovascular Physiology
  • Maternal-Fetal Health
  • Iron Metabolism

Background:

  • Iron homeostasis dysregulation affects adult cardiac function in a sex-specific manner.
  • The long-term impact of maternal iron status during pregnancy on offspring cardiovascular health, and its sex-dependency, remains unclear.

Purpose of the Study:

  • To investigate the sex-specific association between maternal iron status in early pregnancy and cardiac outcomes in 10-year-old children.
  • To determine if maternal anemia or iron levels influence children's cardiac structure and function.

Main Methods:

  • A population-based cohort study of 1972 mother-child pairs.
  • Maternal hemoglobin and ferritin measured in early pregnancy; cardiac MRI at age 10 to assess cardiac function (RVEDV, LVEDV, RVEF, LVEF) and structure (LVM, LMVR).
  • Analysis stratified by sex, with adjustments for confounders and multiple testing.

Main Results:

  • In boys, increased maternal hemoglobin was associated with smaller right and left ventricular end-diastolic volumes (RVEDV and LVEDV).
  • Maternal anemia in early pregnancy was linked to higher LVEDV in boys at age 10.
  • No significant associations were found for other cardiac outcomes or in girls.

Conclusions:

  • Maternal iron status dysregulation during early pregnancy may have lasting effects on boys' cardiac function, specifically RVEDV and LVEDV.
  • Further research is needed to elucidate the underlying mechanisms of these sex-specific cardiovascular alterations.
Abstract

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.2K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
128
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
298
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.9K